Dose of diltiazem for atrial fibrillation
Pro Research Analysisby 
Searched over 200M research papers
Optimal Diltiazem Dosage for Atrial Fibrillation
Introduction to Diltiazem for Atrial Fibrillation
Atrial fibrillation (AF) is a common cardiac arrhythmia characterized by rapid and irregular beating. Diltiazem, a calcium channel blocker, is frequently used to control the ventricular rate in patients with AF. This article synthesizes research findings on the optimal dosing of diltiazem for effective rate control in AF patients.
Intravenous Diltiazem Dosage
Initial Bolus and Continuous Infusion
Several studies have evaluated the efficacy of intravenous diltiazem in controlling heart rate in AF patients. A common initial approach involves a bolus dose followed by a continuous infusion. One study demonstrated that an initial bolus of 0.25 mg/kg over 2 minutes, followed by a second bolus of 0.35 mg/kg if needed, was effective in achieving a therapeutic response in 93% of patients . Another study confirmed the efficacy of this regimen, showing a significant reduction in heart rate within 5 minutes of administration .
Continuous Infusion Rates
For continuous infusion, doses typically range from 5 to 15 mg/hour. Research indicates that a 10-15 mg/hour infusion maintains a therapeutic response in 74% of patients over 24 hours . Another study found that titrating the infusion from 5 mg/hour to 15 mg/hour resulted in a sustained response in 76% of patients .
Safety and Efficacy in Different Patient Populations
Patients with Congestive Heart Failure
In patients with moderate to severe congestive heart failure, intravenous diltiazem at doses of 0.25 mg/kg and 0.35 mg/kg was found to be safe and effective, with a 97% response rate . This suggests that diltiazem can be used effectively even in patients with compromised cardiac function.
Comparison with Digoxin
When compared to digoxin, diltiazem was superior in rapidly controlling heart rate. Diltiazem achieved significant heart rate reduction within 5 minutes, whereas digoxin took up to 3 hours to show a similar effect . This makes diltiazem a preferred choice for emergency rate control in acute AF.
Low-Dose Diltiazem
Efficacy and Safety
A study comparing different doses of diltiazem found that low-dose diltiazem (≤ 0.2 mg/kg) was as effective as standard doses (0.2-0.3 mg/kg) in controlling rapid AF, with a significantly lower risk of hypotension . This suggests that lower doses may be preferable in patients at risk of hypotension.
Conclusion
Intravenous diltiazem is highly effective for rate control in atrial fibrillation, with an initial bolus of 0.25 mg/kg followed by a continuous infusion of 10-15 mg/hour being commonly used. This regimen is effective across various patient populations, including those with congestive heart failure. Low-dose diltiazem may offer a safer alternative for patients prone to hypotension. Overall, diltiazem remains a cornerstone in the management of AF due to its rapid onset and high efficacy.
Sources and full results
Most relevant research papers on this topic
Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure.
Intravenous diltiazem is a safe and effective treatment for patients with atrial fibrillation or flutter and moderate to severe congestive heart failure, with 97% having a therapeutic response.
Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group.
Intravenous diltiazem is rapidly effective in slowing heart rate in most patients with atrial fibrillation or atrial flutter, with mild side effects.
Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter.
Intravenous diltiazem effectively reduces heart rate and improves symptoms in patients with atrial fibrillation or atrial flutter, with a maximum response at 15 mg/hour.
Improving Appropriate Dosing of Intravenous dilTIAZem in Patients With Atrial Fibrillation or Flutter With Rapid Ventricular Response in the Emergency Department.
Adding a text alert to dilTIAZem withdrawal significantly increased appropriate doses in emergency department patients with atrial fibrillation or flutter, but did not significantly decrease hypotension incidence.
DOI